We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Contrast-Enhanced Spectral Mammography Minimizes Diagnosis Delays

By HospiMedica International staff writers
Posted on 15 Mar 2012
A new breast imaging scanning procedure has been developed to be simple: after an intravenous injection of contrast dye (similar to magnetic resonance imaging [MRI]), the patient receives a mammogram using contrast-enhanced spectral mammography (CESM) technology, which basically analyzes blood flow patterns within the breast tissue to create a precise image of normal versus abnormal findings. More...


The Pink Lotus Breast Center, a breast center focused on the prevention, screening, diagnosis, and treatment of breast cancer, announced the unveiling of GE Healthcare’s CESM technology at its flagship breast center in Beverly Hills, CA, USA. CESM will be provided at the facility’s Sheryl Crow Imaging Center--the first facility in the United States to make this new advancement available to patients.

“We expect CESM to minimize the anxiety-provoking delay between finding something on screening mammography that might be cancer, and giving a woman definitive answers with a plan,” said Kristi Funk, MD, founder of the Pink Lotus Breast Center.

When an inconclusive mammogram and ultrasound require additional testing, scheduling, and completing the next step--such as MRI--frequently creates an indirect and lengthy path that may not even lead to a diagnosis. CESM lessens this path for many patients in several ways: (1) a CESM scan only takes a little longer than a diagnostic mammogram, and uses the same equipment as a routine mammogram, which patients already understand; (2) the CESM technology clearly isolates concerning lesions while hiding noncancerous tissue, thus eliminating the ambiguity of the initial study; (3) unlike MRI, CESM is not hindered by hormone replacement or menstrual cycles, so CESM can be scheduled immediately with findings available within minutes; and (4) compared to MRI, CESM does not cause as much discomfort or claustrophobia, and is four times faster.

“More than ever before, patients who have an inconclusive mammogram can expedite their path to a diagnosis using CESM,” remarked Lori-Beth Sewell, chief operating officer at the Pink Lotus Breast Center. “This further sets us apart from other organizations that are often so departmentally fragmented that the path to diagnosis can last weeks or even longer.”

As a comprehensive breast center, the Pink Lotus Breast Center provides new technologic developments such as CESM, as well as in offering a wide variety of screening and diagnostic tools that allow patients to be quickly diagnosed, minimizing their anxiety over the unknown. This is why GE Healthcare (Chalfont St. Giles, UK) selected the Pink Lotus Breast Center to launch its CESM technology, which carries the brand name SenoBright. CESM considerably reduces patient anxieties by resolving inconclusive findings with a short wait.

Related Links:

GE Healthcare
Pink Lotus Breast Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.